What This Means
This research examined two common procedures used to treat atrial fibrillation (an irregular heart rhythm): pulsed field ablation (PFA), which uses electrical pulses to destroy abnormal heart tissue, and cryoballoon ablation (CRYO), which uses freezing. The study followed 33 patients at a single hospital, measuring blood markers before the procedure, immediately after, and the following day. Both procedures caused a notable drop in hemoglobin (a protein in red blood cells), but the drop was similar between the two groups. However, bilirubin — a substance released when red blood cells break down — rose significantly more in patients who had PFA, suggesting that PFA may cause more red blood cell destruction (hemolysis) than CRYO.
Despite the bilirubin difference, neither procedure caused kidney damage as defined by established clinical criteria (KDIGO), and creatinine levels (a marker of kidney function) barely changed in either group. This is notable because one concern with hemolysis is that the byproducts of red blood cell breakdown could potentially harm the kidneys, but this was not observed in this small study.
This research suggests that PFA may produce a greater degree of red blood cell breakdown than cryoballoon ablation, as reflected in higher bilirubin levels, though no kidney injury was detected in either group. Because the study was small (33 patients) and did not directly measure hemolysis with specialized tests, the authors emphasize that larger studies using dedicated hemolysis biomarkers are needed to confirm these findings and better understand the clinical significance of this difference between ablation techniques.